Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex Differences in the Burden of Atrial Fibrillation/Flutter and Associated Heart Failure Stratified by Age at Onset.

Pacing and clinical electrophysiology : PACE·2026
Same author

Instantaneous Lipid Profiling in Rat Cerebrospinal Fluid via a Nanoconfined Sampling Extraction and Grouping Separation Integrated System: Overcoming Ex Vivo Degradation.

Analytical chemistry·2026
Same author

Finerenone vs. spironolactone to reduce adverse outcomes in patients with cardiac-kidney-metabolic syndrome complicated by atrial fibrillation: findings from the Tianjin atrial fibrillation project.

European heart journal open·2026
Same author

Discovery of Highly Potent and Selective SOS1 Inhibitors for the Treatment of KRAS-Driven Colorectal Cancer.

Journal of medicinal chemistry·2026
Same author

P-Selectin Inhibition and the Structure-Activity Relationship of Sea Cucumber-Derived Fucosylated Glycosaminoglycan Oligosaccharides.

Marine drugs·2026
Same author

Unveiling and suppressing side reactions in the deacetylation and deaminative depolymerization of fucosylated chondroitin sulfate for enhanced oligosaccharide preparation.

Carbohydrate polymers·2026
Same journal

Cardiomyocyte-derived USP20 mitigates myocardial ischemia/reperfusion injury through deubiquitinating GRP78.

Theranostics·2026
Same journal

Ion-Responsive Microneedles Delivering Subtype-Specific Mitochondrial Extracellular Vesicles from HEY1⁺ Cardiomyocytes for Cardiac Repair in Bama Minipigs with Myocardial Ischemia-Reperfusion Injury.

Theranostics·2026
Same journal

Mechano-immune interactions in musculoskeletal aging: Mechanisms and translational perspectives.

Theranostics·2026
Same journal

Peripheral blood immune profiling reveals key signatures in newly diagnosed NK/T cell lymphoma patients.

Theranostics·2026
Same journal

Sonogenetics for precision medicine: from molecular toolkit to clinical translation.

Theranostics·2026
Same journal

Programmable pH-responsive DNA inter-strand matching (PRISM) for precision molecular band-pass actuation.

Theranostics·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

1.0K

Radiolabeled nanoparticles for multimodality tumor imaging.

Yan Xing1, Jinhua Zhao2, Peter S Conti3

  • 11. Molecular Imaging Center, Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA ; 2. Department of Nuclear Medicine, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai 200080, China.

Theranostics
|February 8, 2014
PubMed
Summary
This summary is machine-generated.

Multimodality imaging combines strengths of different techniques for better cancer diagnosis. Radiolabeled nanoparticles show promise for advanced tumor imaging and personalized cancer medicine.

Keywords:
cancermolecular imagingmultimodality imagingradiolabeled nanoparticlestheranosticstumor diagnosis

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.2K
Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy
07:13

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy

Published on: May 16, 2022

1.8K

Related Experiment Videos

Last Updated: May 3, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

1.0K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.2K
Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy
07:13

Biomolecular Imaging of Cellular Uptake of Nanoparticles using Multimodal Nonlinear Optical Microscopy

Published on: May 16, 2022

1.8K

Area of Science:

  • Biomedical Engineering
  • Radiochemistry
  • Nanotechnology

Background:

  • Multimodality imaging leverages complementary strengths of various imaging techniques.
  • Molecular imaging is crucial for cancer diagnosis and treatment monitoring.
  • Radiolabeled nanoparticles offer unique advantages for multimodal tumor imaging.

Purpose of the Study:

  • To review the advantages and challenges of developing multimodality imaging probes using nanoparticles.
  • To summarize recent advances in radiolabeled nanoparticles for multimodal tumor imaging.
  • To discuss the clinical translation of these advanced imaging agents.

Main Methods:

  • Review of literature on nanoparticle-based multimodal imaging probes.
  • Analysis of radiolabeling strategies for various nanoparticle types.
  • Evaluation of applications in preclinical and clinical tumor imaging.

Main Results:

  • Significant progress in developing radiolabeled nanoparticles for multimodal cancer imaging.
  • Demonstrated potential for improved diagnostic and therapeutic monitoring.
  • Identified key challenges in clinical translation.

Conclusions:

  • Radiolabeled nanoparticles are valuable tools for multimodal tumor imaging.
  • Quantitative imaging with these agents can enable personalized cancer medicine.
  • Further research is needed to overcome clinical translation hurdles.